Roche Holding AG (OTCMKTS:RHHBY) Stock Has Average Target Price of $60.00 According to Analysts

Roche Holding AG (OTCMKTS:RHHBY) has received a consensus rating of “Moderate Buy” from the fourteen research firms that are currently covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a hold recommendation and eight have given a buy recommendation to the company. The average 1-year target price among brokers that have covered the stock in the last year is $60.00.

Several brokerages recently weighed in on RHHBY. UBS Group downgraded shares of Roche from a “strong-buy” rating to a “hold” rating in a report on Monday, November 2nd. HSBC reiterated a “hold” rating on shares of Roche in a research note on Thursday, September 10th. Morgan Stanley raised Roche from an “equal weight” rating to an “overweight” rating and set a $63.00 price target on the stock in a report on Friday, August 7th. Deutsche Bank upgraded Roche from a “hold” rating to a “buy” rating in a research report on Friday, October 23rd. Finally, Zacks Research raised Roche from a “strong sell” rating to a “hold” rating in a research note on Monday, August 24th.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in RHHBY. McIlrath & Eck LLC purchased a new stake in Roche during the 1st quarter valued at approximately $39,000. Renasant Bank bought a new stake in shares of Roche during the second quarter valued at approximately $210,000. Woodstock Corp bought a new stake in shares of Roche during the third quarter valued at approximately $245,000. Enterprise Financial Services Corp lifted its holdings in shares of Roche by 6.6% in the first quarter. Enterprise Financial Services Corp now owns 5,576 shares of the company’s stock worth $277,000 after buying an additional 345 shares in the last quarter. Finally, Archer Investment Corp lifted its holdings in shares of Roche by 7.7% in the first quarter. Archer Investment Corp now owns 5,598 shares of the company’s stock worth $278,000 after buying an additional 398 shares in the last quarter.

Roche Price Performance

Shares of OTCMKTS RHHBY opened at $60.57 on Friday. Roche has a 1 year low of $44.57 and a 1 year high of $61.75. The firm has a fifty day moving average price of $56.28 and a 200-day moving average price of $53.97. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.23 and a quick ratio of 0.95.

Roche Company Profile

Roche is a Swiss healthcare company with two main businesses: pharmaceuticals and diagnostics. Founded in Basel in 1896, the company develops and commercializes medicines and provides diagnostic tests, instruments, and digital health solutions. Its pharmaceutical research and products span areas including oncology, immunology, neuroscience, ophthalmology, and infectious diseases. Its diagnostics business serves clinical laboratories, hospitals, healthcare providers, and patients with tools used to detect and monitor a range of medical conditions.